Table 1.
Control Subjects (n = 18) |
SBD-REM (n = 16) |
SBD-CUR (n = 14) |
|
---|---|---|---|
Age, years a | 37.8 ± 7.8 | 36.9 ± 11.4 | 33.0 ± 6.9 |
Gender | 9 M/9 F | 5 M/11 F | 7 M/7 F |
HAM-D | … | 26.4 ± 4.5 | 28.0 ± 4.3 |
Melancholic features (n) | … | 4 | 4 |
TSA, months | … | 17.2 ± 3.1 | 3.9 ± 3.2 ††† |
NSA | … | 1.4 ± 0.6 | 1.3 ± 0.6 |
8 AM and 11 PM TRH tests | |||
8 AM-FT4BL, pmol/L | 13.6 ± 1.5 | 14.5 ± 3.0 | 12.3 ± 2.1 * |
8 AM-FT3BL, pmol/L | 5.1 ± 0.4 | 5.5 ± 0.7 | 5.3 ± 0.8 |
8 AM-TSHBL, mU/L | 1.23 ± 0.44 | 1.42 ± 0.69 | 1.10 ± 0.38 |
8 AM-∆TSH, mU/L | 9.32 ± 4.41 | 8.83 ± 3.61 | 7.30 ± 3.60 |
11 PM-TSHBL, mU/L | 1.33 ± 0.75 | 1.12 ± 0.52 | 0.75 ± 0.29 * |
11 PM-∆TSH, mU/L | 13.66 ± 4.94 | 12.35 ± 3.67 | 9.00 ± 3.93 **† |
∆∆TSH, mU/L | 4.31 ± 1.16 | 3.54 ± 1.63 | 1.67 ± 2.55 ***† |
Apomorphine test | |||
ACTHBL (ng/L) | 23.0 ± 17.1 | 20.0 ± 8.6 | 30.9 ± 19.9 |
∆ACTH (ng/L) | 24.8 ± 30.1 | 19.2 ± 22.7 | 44.1 ± 38.2 *† |
CORBL (nmol/L) | 282 ± 110 | 321 ±114 | 251 ± 77 |
∆COR (nmol/L) | 176 ± 181 | 111 ± 131 | 167 ± 124 |
GHBL (µg/L) | 0.6 ± 0.3 | 0.7 ± 0.3 | 0.7 ± 0.4 |
∆GH (µg/L) | 12.0 ± 7.4 | 8.9 ± 8.3 | 21.0 ± 13.0 *††† |
Maximum post-DST | |||
COR, nmol/L | 44 ± 56 | 85 ± 103 | 66 ± 62 |
a Values are mean ± SD. SBD, suicidal behavior disorder; CUR, current; REM, early remission; HAM-D, 17-item Hamilton Rating Scale for Depression; TSA, time elapsed between the last suicide attempt and the investigation; NSA, number of suicide attempts; FT4, free thyroxine; T3, free triiodothyronine; TSH, thyrotropin; ACTH, adrenocorticotropin hormone; COR, cortisol; GH, growth hormone; BL, basal concentration; ∆, peak concentration minus basal concentration; ∆∆TSH, 2300h-∆TSH minus 0800h-∆TSH; DST, dexamethasone suppression test. Comparisons between control and depressed groups, * p ≤ 0.05; ** p≤ 0.01; *** p ≤ 0.005; comparisons between SBD-REM and SBD-CUR groups, † p ≤ 0.05; ††† p ≤ 0.005 (by U-test).